Cargando…
Effects of PD-1 Signaling on Immunometabolic Reprogramming
Programmed Death-1 (PD-1; CD279) is an inhibitory receptor induced in several activated immune cells and, after engagement with its ligands PD-L1 and PD-L2, serves as a key mediator of peripheral tolerance. However, PD-1 signaling also has detrimental effects on T cell function by posing breaks on a...
Autores principales: | Boussiotis, Vassiliki A., Patsoukis, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975241/ https://www.ncbi.nlm.nih.gov/pubmed/35371563 http://dx.doi.org/10.20900/immunometab20220007 |
Ejemplares similares
-
Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses
por: Patsoukis, Nikolaos, et al.
Publicado: (2017) -
Revisiting the PD-1 pathway
por: Patsoukis, Nikolaos, et al.
Publicado: (2020) -
Clinical significance of T cell metabolic reprogramming in cancer
por: Herbel, Christoph, et al.
Publicado: (2016) -
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
por: Patsoukis, Nikolaos, et al.
Publicado: (2015) -
Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells
por: Li, Lequn, et al.
Publicado: (2012)